Huvepharma EOOD
Huvepharma EOOD, a prominent player in the pharmaceutical industry, is headquartered in Bulgaria (BG) and operates extensively across Europe, North America, and Asia. Founded in 2001, the company has established itself as a leader in the development and production of veterinary pharmaceuticals, with a strong focus on animal health and nutrition.
Huvepharma's core offerings include a diverse range of products such as antibiotics, vaccines, and nutritional supplements, all designed to enhance animal welfare and productivity. What sets Huvepharma apart is its commitment to innovation and quality, ensuring that its products meet the highest industry standards. With a robust market position, the company has achieved significant milestones, including numerous regulatory approvals and partnerships that underscore its reputation in the global market.
-17 vs industry average
Huvepharma EOOD’s score of 21 is lower than 43% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Huvepharma EOOD?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Huvepharma EOOD yet.
Huvepharma EOOD's reported carbon emissions
Huvepharma EOOD, headquartered in Bulgaria (BG), currently does not report any specific carbon emissions data for the most recent year. However, the company has set ambitious climate commitments aimed at achieving carbon neutrality.
Huvepharma is targeting a 100% reduction in Scope 1 and Scope 2 emissions by 2030. This commitment involves significant investments in renewable energy and the implementation of processes designed to protect the planet's resources. The company aims to be carbon neutral at its production sites by the end of this target period.
As a current subsidiary, Huvepharma's climate initiatives are part of a broader corporate strategy, although specific emissions data cascaded from a parent organization is not available. The company's proactive approach to sustainability reflects its commitment to addressing climate change and reducing its environmental impact.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Huvepharma EOOD’s Climate Goals (2030 & 2050)
2 goals2030
100% reduction in Scope 2
By investing in renewable energy and
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project